 | NQI | Name: | N~2~-[(2S)-2-{[(2R)-4-ETHOXY-2-HYDROXY-4-OXOBUTANOYL]AMINO}PENT-4-ENOYL]-L-ARGINYL-L-TRYPTOPHANAMIDE | Formula: | C28 H40 N8 O7 | SMILES: | O=C(OCC)CC(O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc2c1ccccc1nc2)CCCNC(=[N@H])N)CC=C | InChi: | InChI=1S/C28H40N8O7/c1-3-8-19(35-27(42)22(37)14-23(38)43-4-2)25(40)34-20(11-7-12-32-28(30)31)26(41)36-21(24(29)39)13-16-15-33-18-10-6-5-9-17(16)18/h3,5-6,9-10,15,19-22,33,37H,1,4,7-8,11-14H2,2H3,(H2,29,39)(H,34,40)(H,35,42)(H,36,41)(H4,30,31,32)/t19-,20-,21-,22+/m0/s1 | Definition date: | 2006-11-09 | Last modified: | 2024-09-27 | Identifier: | N~2~-[(2S)-2-{[(2R)-4-ethoxy-2-hydroxy-4-oxobutanoyl]amino}pent-4-enoyl]-L-arginyl-L-tryptophanamide |
|
 | O5S | Name: | 2-[5-chloro-2-cyclopropyl-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-7-methyl-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C31 H35 Cl N4 O4 | SMILES: | CCC(N6CC(NC(=O)Cn1c5c(c(c1C2CC2)C(N4CCc3c(OC)cccc3C4)=O)cc(Cl)cc5C)C6)=O | InChi: | InChI=1S/C31H35ClN4O4/c1-4-27(38)35-15-22(16-35)33-26(37)17-36-29-18(2)12-21(32)13-24(29)28(30(36)19-8-9-19)31(39)34-11-10-23-20(14-34)6-5-7-25(23)40-3/h5-7,12-13,19,22H,4,8-11,14-17H2,1-3H3,(H,33,37) | Definition date: | 2019-06-12 | Last modified: | 2024-09-27 | Release date: | 2019-08-28 | Identifier: | 2-[5-chloro-2-cyclopropyl-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-7-methyl-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide |
|
 | WPL | Name: | (1~{S},3~{S},4~{R},5~{R})-3-methyl-1,4,5-tris(hydroxyl)cyclohexane-1-carboxylic acid | Formula: | C8 H14 O5 | SMILES: | C[CH]1C[C](O)(C[CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C8H14O5/c1-4-2-8(13,7(11)12)3-5(9)6(4)10/h4-6,9-10,13H,2-3H2,1H3,(H,11,12)/t4-,5+,6+,8-/m0/s1 | Definition date: | 2014-01-15 | Last modified: | 2024-09-27 | Release date: | 2014-11-05 | Identifier: | (1~{S},3~{S},4~{R},5~{R})-3-methyl-1,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid |
|
 | SNC | Name: | S-NITROSO-CYSTEINE | Formula: | C3 H6 N2 O3 S | SMILES: | O=C(O)C(N)CSN=O | InChi: | InChI=1S/C3H6N2O3S/c4-2(3(6)7)1-9-5-8/h2H,1,4H2,(H,6,7)/t2-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | S-nitroso-L-cysteine |
|
 | NQL | Name: | 2-chloranyl-N-[[1-(4-phenylazanylpiperidin-4-yl)carbonylpiperidin-4-yl]methyl]ethanamide | Formula: | C20 H29 Cl N4 O2 | SMILES: | ClCC(=O)NCC1CCN(CC1)C(=O)C2(CCNCC2)Nc3ccccc3 | InChi: | InChI=1S/C20H29ClN4O2/c21-14-18(26)23-15-16-6-12-25(13-7-16)19(27)20(8-10-22-11-9-20)24-17-4-2-1-3-5-17/h1-5,16,22,24H,6-15H2,(H,23,26) | Definition date: | 2022-08-17 | Last modified: | 2024-09-27 | Release date: | 2023-09-20 | Identifier: | 2-chloranyl-~{N}-[[1-(4-phenylazanylpiperidin-4-yl)carbonylpiperidin-4-yl]methyl]ethanamide |
|
 | S7Z | Name: | (E)-(4-((2,6-difluoro-4-(hydroxymethyl)phenyl)diazenyl)-2,6-difluorophenyl)methanol | Formula: | C14 H6 F4 N2 O4 | SMILES: | OC(=O)c1cc(F)c(N=Nc2c(F)cc(cc2F)C(O)=O)c(F)c1 | InChi: | InChI=1S/C14H6F4N2O4/c15-7-1-5(13(21)22)2-8(16)11(7)19-20-12-9(17)3-6(14(23)24)4-10(12)18/h1-4H,(H,21,22)(H,23,24)/b20-19- | Synonyms: | [4-[(~{Z})-[2,6-bis(fluoranyl)-4-(hydroxymethyl)phenyl]diazenyl]-3,5-bis(fluoranyl)phenyl]methanol | Definition date: | 2020-11-11 | Last modified: | 2024-09-27 | Release date: | 2021-12-15 | Identifier: | 4-[(~{Z})-[4-carboxy-2,6-bis(fluoranyl)phenyl]diazenyl]-3,5-bis(fluoranyl)benzoic acid |
|
 | KXL | Name: | (2S)-N-[(2S)-1-(dimethylamino)-1-oxidanylidene-3-phenyl-propan-2-yl]-2-oxidanyl-N'-(2-pyridin-2-ylethyl)butanediamide | Formula: | C22 H28 N4 O4 | SMILES: | CN(C)C(=O)[CH](Cc1ccccc1)NC(=O)[CH](O)CC(=O)NCCc2ccccn2 | InChi: | InChI=1S/C22H28N4O4/c1-26(2)22(30)18(14-16-8-4-3-5-9-16)25-21(29)19(27)15-20(28)24-13-11-17-10-6-7-12-23-17/h3-10,12,18-19,27H,11,13-15H2,1-2H3,(H,24,28)(H,25,29)/t18-,19-/m0/s1 | Definition date: | 2022-06-07 | Last modified: | 2024-09-27 | Release date: | 2023-11-29 | Identifier: | (2~{S})-~{N}-[(2~{S})-1-(dimethylamino)-1-oxidanylidene-3-phenyl-propan-2-yl]-2-oxidanyl-~{N}'-(2-pyridin-2-ylethyl)butanediamide |
|
 | YAZ | Name: | (2E)-3-(3-chloro-4-hydroxyphenyl)prop-2-enoic acid | Formula: | C9 H7 Cl O3 | SMILES: | C(=O)(O)C=Cc1cc(Cl)c(cc1)O | InChi: | InChI=1S/C9H7ClO3/c10-7-5-6(1-3-8(7)11)2-4-9(12)13/h1-5,11H,(H,12,13)/b4-2+ | Definition date: | 2018-09-19 | Last modified: | 2024-09-27 | Release date: | 2019-05-29 | Identifier: | (2E)-3-(3-chloro-4-hydroxyphenyl)prop-2-enoic acid |
|
 | O5V | Name: | 2-[4-bromo-2-(3-phenyl-2,5-dihydro-1H-pyrrole-1-carbonyl)phenoxy]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C25 H26 Br N3 O4 | SMILES: | CCC(=O)N1CC(C1)NC(=O)COc2ccc(Br)cc2C(N4CC=C(c3ccccc3)C4)=O | InChi: | InChI=1S/C25H26BrN3O4/c1-2-24(31)29-14-20(15-29)27-23(30)16-33-22-9-8-19(26)12-21(22)25(32)28-11-10-18(13-28)17-6-4-3-5-7-17/h3-10,12,20H,2,11,13-16H2,1H3,(H,27,30) | Definition date: | 2019-06-12 | Last modified: | 2024-09-27 | Release date: | 2019-08-28 | Identifier: | 2-[4-bromo-2-(3-phenyl-2,5-dihydro-1H-pyrrole-1-carbonyl)phenoxy]-N-(1-propanoylazetidin-3-yl)acetamide |
|
 | X5H | Name: | (~{E})-6-(2-hydroxy-2-oxoethylamino)hex-4-enoic acid | Formula: | C8 H13 N O4 | SMILES: | OC(=O)CCC=CCNCC(O)=O | InChi: | InChI=1S/C8H13NO4/c10-7(11)4-2-1-3-5-9-6-8(12)13/h1,3,9H,2,4-6H2,(H,10,11)(H,12,13)/b3-1+ | Definition date: | 2023-05-31 | Last modified: | 2024-09-27 | Release date: | 2023-06-07 | Identifier: | (~{E})-6-(2-hydroxy-2-oxoethylamino)hex-4-enoic acid |
|
 | MJ8 | Name: | 5'-({[(2R)-3-amino-2-{[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl]sulfanyl}propyl]sulfonyl}amino)-5'-deoxyadenosine | Formula: | C24 H42 N9 O12 P S2 | SMILES: | O=S(NCC1C(O)C(O)C(O1)n2cnc3c2ncnc3N)(=O)CC(SCCNC(=O)CCNC(C(O)C(COP(=O)(O)O)(C)C)=O)CN | InChi: | InChI=1S/C24H42N9O12PS2/c1-24(2,10-44-46(39,40)41)19(37)22(38)28-4-3-15(34)27-5-6-47-13(7-25)9-48(42,43)32-8-14-17(35)18(36)23(45-14)33-12-31-16-20(26)29-11-30-21(16)33/h11-14,17-19,23,32,35-37H,3-10,25H2,1-2H3,(H,27,34)(H,28,38)(H2,26,29,30)(H2,39,40,41)/t13-,14-,17-,18-,19+,23-/m1/s1 | Definition date: | 2016-12-20 | Last modified: | 2024-09-27 | Release date: | 2017-05-10 | Identifier: | 5'-({[(2R)-3-amino-2-{[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl]sulfanyl}propyl]sulfonyl}amino)-5'-deoxyadenosine |
|
 | XXN | Name: | (3S)-4,7-dichloro-3-hydroxy-1,3-dihydro-2H-indol-2-one | Formula: | C8 H5 Cl2 N O2 | SMILES: | Clc1ccc(Cl)c2c1NC(=O)C2O | InChi: | InChI=1S/C8H5Cl2NO2/c9-3-1-2-4(10)6-5(3)7(12)8(13)11-6/h1-2,7,12H,(H,11,13)/t7-/m0/s1 | Definition date: | 2023-11-14 | Last modified: | 2024-09-27 | Release date: | 2024-02-14 | Identifier: | (3S)-4,7-dichloro-3-hydroxy-1,3-dihydro-2H-indol-2-one |
|
 | U9O | Name: | 5-azanyl-1-oxidanyl-pentan-2-one | Formula: | C5 H11 N O2 | SMILES: | NCCCC(=O)CO | InChi: | InChI=1S/C5H11NO2/c6-3-1-2-5(8)4-7/h7H,1-4,6H2 | Definition date: | 2023-08-31 | Last modified: | 2024-09-27 | Release date: | 2024-02-21 | Identifier: | 5-azanyl-1-oxidanyl-pentan-2-one |
|
 | KIH | Name: | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine | Formula: | C23 H23 F N4 O5 S | SMILES: | COc1ccc(cc1OC)c2c(C)nn3c(NCc4ccc(O[S](F)(=O)=O)cc4)cc(C)nc23 | InChi: | InChI=1S/C23H23FN4O5S/c1-14-11-21(25-13-16-5-8-18(9-6-16)33-34(24,29)30)28-23(26-14)22(15(2)27-28)17-7-10-19(31-3)20(12-17)32-4/h5-12,25H,13H2,1-4H3 | Definition date: | 2023-08-14 | Last modified: | 2024-09-27 | Release date: | 2023-12-13 | Identifier: | 3-(3,4-dimethoxyphenyl)-7-[(4-fluorosulfonyloxyphenyl)methylamino]-2,5-dimethyl-pyrazolo[1,5-a]pyrimidine |
|
 | ZQN | Name: | N-(TERT-BUTYLOXYCARBONYL)-VALINE | Formula: | C10 H19 N O4 | SMILES: | CC(C)[CH](NC(=O)OC(C)(C)C)C(O)=O | InChi: | InChI=1S/C10H19NO4/c1-6(2)7(8(12)13)11-9(14)15-10(3,4)5/h6-7H,1-5H3,(H,11,14)(H,12,13)/t7-/m0/s1 | Synonyms: | N-BOC-VALINE | Definition date: | 2024-01-22 | Last modified: | 2024-09-27 | Release date: | 2024-05-29 | Identifier: | 3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid |
|
 | UN1 | Name: | 2-AMINOHEXANEDIOIC ACID | Formula: | C6 H11 N O4 | SMILES: | O=C(O)CCCC(N)C(=O)O | InChi: | InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)/t4-/m0/s1 | Definition date: | 2002-06-19 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-aminohexanedioic acid |
|
 | OLD | Name: | 3-[2-(4-bromophenyl)-2-oxoethyl]-L-histidine | Formula: | C14 H14 Br N3 O3 | SMILES: | O=C(c1ccc(Br)cc1)Cn2c(cnc2)CC(C(=O)O)N | InChi: | InChI=1S/C14H14BrN3O3/c15-10-3-1-9(2-4-10)13(19)7-18-8-17-6-11(18)5-12(16)14(20)21/h1-4,6,8,12H,5,7,16H2,(H,20,21)/t12-/m0/s1 | Definition date: | 2009-06-26 | Last modified: | 2024-09-27 | Release date: | 2012-10-12 | Identifier: | 3-[2-(4-bromophenyl)-2-oxoethyl]-L-histidine |
|
 | O5Y | Name: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C27 H29 Br N4 O4 | SMILES: | CCC(N5CC(NC(=O)Cn3cc(C(=O)N1Cc2c(CC1)c(ccc2)OC)c4cc(Br)ccc34)C5)=O | InChi: | InChI=1S/C27H29BrN4O4/c1-3-26(34)32-13-19(14-32)29-25(33)16-31-15-22(21-11-18(28)7-8-23(21)31)27(35)30-10-9-20-17(12-30)5-4-6-24(20)36-2/h4-8,11,15,19H,3,9-10,12-14,16H2,1-2H3,(H,29,33) | Definition date: | 2019-06-12 | Last modified: | 2024-09-27 | Release date: | 2019-08-28 | Identifier: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide |
|
 | 4H0 | Name: | (3S)-3-amino-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid | Formula: | C11 H9 F4 N O4 | SMILES: | O=C(O)CC(C(=O)COc1c(F)c(F)cc(F)c1F)N | InChi: | InChI=1S/C11H9F4NO4/c12-4-1-5(13)10(15)11(9(4)14)20-3-7(17)6(16)2-8(18)19/h1,6H,2-3,16H2,(H,18,19)/t6-/m0/s1 | Definition date: | 2012-12-13 | Last modified: | 2024-09-27 | Release date: | 2013-03-20 | Identifier: | (3S)-3-amino-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
|
 | UN2 | Name: | 2-AMINO-4,4-DIHYDROXYBUTANOIC ACID | Formula: | C4 H9 N O4 | SMILES: | O=C(O)C(N)CC(O)O | InChi: | InChI=1S/C4H9NO4/c5-2(4(8)9)1-3(6)7/h2-3,6-7H,1,5H2,(H,8,9)/t2-/m0/s1 | Definition date: | 2002-06-19 | Last modified: | 2024-09-27 | Identifier: | 4-hydroxy-L-homoserine |
|
 | VUZ | Name: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide | Formula: | C22 H20 Cl N7 O | SMILES: | CCn1cc(Nc2nc(Nc3cccc(NC(=O)C=C)c3)c4cc(Cl)ccc4n2)cn1 | InChi: | InChI=1S/C22H20ClN7O/c1-3-20(31)25-15-6-5-7-16(11-15)26-21-18-10-14(23)8-9-19(18)28-22(29-21)27-17-12-24-30(4-2)13-17/h3,5-13H,1,4H2,2H3,(H,25,31)(H2,26,27,28,29) | Definition date: | 2023-08-21 | Last modified: | 2024-09-27 | Release date: | 2024-08-21 | Identifier: | ~{N}-[3-[[6-chloranyl-2-[(1-ethylpyrazol-4-yl)amino]quinazolin-4-yl]amino]phenyl]prop-2-enamide |
|
 | KIK | Name: | (4~{S})-4-azanyl-5-oxidanyl-pent-1-en-3-one | Formula: | C5 H9 N O2 | SMILES: | N[CH](CO)C(=O)C=C | InChi: | InChI=1S/C5H9NO2/c1-2-5(8)4(6)3-7/h2,4,7H,1,3,6H2/t4-/m0/s1 | Definition date: | 2016-08-23 | Last modified: | 2024-09-27 | Release date: | 2017-01-18 | Identifier: | (4~{S})-4-azanyl-5-oxidanyl-pent-1-en-3-one |
|
 | T1O | Name: | 5-[(3aS,4R,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-oxopropyl)pentanamide | Formula: | C13 H21 N3 O3 S | SMILES: | O=C2NC1C(SCC1N2)CCCCC(=O)NCC(=O)C | InChi: | InChI=1S/C13H21N3O3S/c1-8(17)6-14-11(18)5-3-2-4-10-12-9(7-20-10)15-13(19)16-12/h9-10,12H,2-7H2,1H3,(H,14,18)(H2,15,16,19)/t9-,10+,12-/m0/s1 | Definition date: | 2017-07-08 | Last modified: | 2024-09-27 | Release date: | 2018-07-11 | Identifier: | 5-[(3aS,4R,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-oxopropyl)pentanamide |
|
 | PTD | Name: | PENTANEDIAL | Formula: | C5 H8 O2 | SMILES: | O=CCCCC=O | InChi: | InChI=1S/C5H8O2/c6-4-2-1-3-5-7/h4-5H,1-3H2 | Definition date: | 2000-07-12 | Last modified: | 2024-09-27 | Identifier: | pentanedial |
|
 | NQS | Name: | 2-[(2-hydroxyethyl)sulfanyl]naphthalene-1,4-dione | Formula: | C12 H10 O3 S | SMILES: | O=C2c1c(cccc1)C(=O)C(SCCO)=C2 | InChi: | InChI=1S/C12H10O3S/c13-5-6-16-11-7-10(14)8-3-1-2-4-9(8)12(11)15/h1-4,7,13H,5-6H2 | Definition date: | 2014-04-24 | Last modified: | 2024-09-27 | Release date: | 2014-11-05 | Identifier: | 2-[(2-hydroxyethyl)sulfanyl]naphthalene-1,4-dione |
|